1. Home
  2. ACU vs SGMO Comparison

ACU vs SGMO Comparison

Compare ACU & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$44.29

Market Cap

154.0M

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.39

Market Cap

135.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
SGMO
Founded
1867
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.0M
135.1M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ACU
SGMO
Price
$44.29
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$5.60
AVG Volume (30 Days)
7.1K
4.3M
Earning Date
02-27-2026
11-06-2025
Dividend Yield
1.46%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$194,960,991.00
$32,875,000.00
Revenue This Year
$2.19
N/A
Revenue Next Year
$4.55
N/A
P/E Ratio
$17.93
N/A
Revenue Growth
2.35
N/A
52 Week Low
$35.20
$0.37
52 Week High
$45.25
$1.40

Technical Indicators

Market Signals
Indicator
ACU
SGMO
Relative Strength Index (RSI) 65.89 41.13
Support Level $42.39 $0.37
Resistance Level $44.08 $0.48
Average True Range (ATR) 1.14 0.03
MACD 0.09 -0.00
Stochastic Oscillator 92.78 30.36

Price Performance

Historical Comparison
ACU
SGMO

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: